(19)
(11) EP 4 823 599 A2

(12)

(88) Date of publication A3:
17.07.2025

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24841349.4

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
A61K 38/26(2006.01)
A61P 3/00(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/26; A61P 3/00; C07K 16/2809; C07K 2317/75; C07K 2317/21; A61K 39/395; A61K 2039/543
 
C-Sets:
  1. A61K 38/26, A61K 2300/00;
  2. A61K 39/395, A61K 2300/00;

(86) International application number:
PCT/US2024/060080
(87) International publication number:
WO 2025/129029 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610355 P
25.10.2024 US 202463712058 P

(71) Applicants:
  • Tiziana Life Sciences PLC
    London Greater London SW1Y 4LB (GB)
  • The Brigham & Women's Hospital, Inc.
    Boston, Massachusetts 02115 (US)

(72) Inventors:
  • CLEMENTI, William A.
    London Greater London SW1Y 4LB (GB)
  • WEINER, Howard L.
    Brookline, Massachusetts 02445 (US)
  • BOULENOUAR, Selma
    Boston, Massachusetts 02115 (US)
  • ELRIFI, Ivor R.
    London Greater London SW1Y 4LB (GB)
  • CERRONE, Gabriele
    London Greater London SW1Y 4LB (GB)

(74) Representative: Abel & Imray LLP 
Westpoint Building James Street West
Bath BA1 2DA
Bath BA1 2DA (GB)

   


(54) COMBINATIONS OF FORALUMAB WITH GLUCAGON-LIKE PEPTIDE 1 (GLP-1) AGONISTS OR SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS AND METHODS OF USE THEREOF